Boston Consulting Group’s Ashkan Afkhami, managing director and senior partner and global leader of healthcare at BCG X, sat down with MobiHealthNews outside of the JPM Healthcare Conference to discuss the strengths and weaknesses…
Continue Reading
Tempus, an AI-powered data company involved in advancing precision medicine, has launched olivia, an AI-enabled personal health concierge app aimed at empowering patients by centralizing patients’ health data and making that data accessible and…
Continue Reading
Atropos Health, a company translating real-world clinical data into real-world evidence (RWE) for decision making, is partnering with xCures, an AI-powered healthcare data retrieval company, to harness RWE-based insights to support patient care.The aim…
Continue Reading
Lindus Health, a company that conducts end-to-end clinical trials for the life sciences sector, announced it raised $55 million in Series B Funding.The round was led by Balderton Capital with participation from Visionaries Club…
Continue Reading
Research conducted on the International Space Station (ISS) may result in early cancer detection, advance treatments for neurodegenerative conditions and improve respiratory therapies.Space Station (ISS) on SpaceX’s 31st Commercial Resupply Services (CRS) was on…
Continue Reading
At a press conference on Tuesday, President Donald Trump announced the formation of Project Stargate, an at least $500 billion investment to build the physical and virtual infrastructure to power AI construction, including “colossal…
Continue Reading
Digital technology is prevalent in hospitals, according to Bernke Papenburg, program manager of Robotics at Rijnstate Hospital, a 700-bed teaching facility in the eastern Netherlands. Papenburg noted that very few procedures or care performed in…
Continue Reading
DarioHealth, a digital chronic condition management platform, closed a $25.6 million private placement of convertible preferred stock, with most of the funds secured from existing shareholders. The balance of the funds was provided by a…
Continue Reading
Absci, a data-first generative AI drug creation company, is partnering with AMD, a semiconductor company, to deploy AMD Instinct accelerators and ROCm software to power vital AI drug discovery workloads, as well as Absci’s…
Continue Reading
On his first day in office of his second term, President Donald Trump revoked Joe Biden’s 2023 executive order, which aimed to establish standards for the safe, secure and trustworthy development of AI across…
Continue Reading
